Coherus Oncology, Inc.
CHRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $126 | $103 | $64 | $417 |
| Short-Term Investments | $0 | $15 | $128 | $0 |
| Receivables | $122 | $261 | $110 | $123 |
| Inventory | $70 | $63 | $39 | $38 |
| Other Curr. Assets | $23 | $35 | $41 | $24 |
| Total Curr. Assets | $342 | $476 | $381 | $602 |
| Property Plant & Equip (Net) | $3 | $5 | $9 | $8 |
| Goodwill | $0 | $1 | $1 | $1 |
| Intangibles | $54 | $71 | $5 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $50 | $77 | $85 | $66 |
| Total NC Assets | $107 | $154 | $100 | $77 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $449 | $630 | $481 | $679 |
| Liabilities | – | – | – | – |
| Payables | $28 | $35 | $12 | $16 |
| Short-Term Debt | $2 | $2 | $4 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $253 | $294 | $123 | $146 |
| Total Curr. Liab. | $283 | $332 | $139 | $165 |
| LT Debt | $268 | $479 | $476 | $416 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $0 | $0 |
| Other NC Liab. | $28 | $11 | $3 | $1 |
| Total NC Liab. | $298 | $491 | $480 | $416 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $7 | $9 | $11 |
| Total Liabilities | $581 | $823 | $618 | $582 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,551 | -$1,580 | -$1,342 | -$1,050 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $1,419 | $1,386 | $1,204 | $1,148 |
| Total Equity | -$132 | -$193 | -$137 | $98 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $449 | $630 | $481 | $679 |
| Net Debt | $144 | $378 | $417 | $2 |